• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-08-31

  Build translation-ready, ARCA-capped and polyadenylated transcripts through one coordinated workflow for vaccine, translation, antisense, and RNAi studies. This practical guide connects bench-scale RNA quality control with the spleen-targeted neoantigen vaccine findings reported in hepatocellular carcinoma research.

• CDELNs Relieve Sertoli Cell Cycle Arrest

  2026-08-31

  The reference study reports that Cistanche deserticola exosome-like nanovesicles protect against cyclophosphamide-induced testicular injury by delivering miR159b-3p to Sertoli cells. The proposed mechanism links heparan sulfate proteoglycan-mediated uptake with suppression of P21 and phosphorylation-dependent CDK1 activation, while human single-cell data provide translational context.

• Nintedanib: ATRX-Aware Angiokinase Research

  2026-08-30

  Nintedanib (BIBF 1120) is a multi-receptor kinase probe for dissecting angiogenesis, fibrosis, and genotype-dependent tumor responses. This article develops an ATRX-aware assay strategy that separates vascular effects from tumor-cell-intrinsic sensitivity.

• Reelin Signaling Enables Ketamine Synaptic Action

  2026-08-29

  The reference study identifies Reelin–Apoer2–Src family kinase signaling as a permissive system required for ketamine-induced hippocampal plasticity and behavioral responses. Its combination of genetic disruption, pharmacological pathway testing, electrophysiology, and behavioral analysis suggests that preserved baseline NMDA receptor function may help determine ketamine responsiveness.

• CGRP/SP–Piezo2 Signaling in Trigeminal Allodynia

  2026-08-28

  Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 positive-feedback loop linking trigeminal root compression, neuroinflammation, and mechanical allodynia. Their combination of behavioral, molecular, pharmacological, and gene-silencing approaches places the TG neuron–Merkel cell axis at the center of peripheral sensitization in trigeminal neuralgia.

• Phebestin: A Bestatin-Related Antiplasmodial Inhibitor

  2026-08-28

  The reference study identifies phebestin as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum, with activity across parasite stages and in mouse malaria models. Its combination of phenotypic, stage-specific, washout, computational, and in vivo evidence supports aminopeptidases as a useful target class while highlighting the limits of translating early efficacy into a therapeutic candidate.

• Dexamethasone (DHAP): Mechanism and Research Use

  2026-08-27

  Dexamethasone is a synthetic glucocorticoid anti-inflammatory research compound that modulates NF-κB-associated inflammation, mesenchymal stem cell differentiation, autophagy, and neuroinflammatory readouts. The A2324 product profile defines its physicochemical handling requirements and identifies model-specific effects that require appropriate vehicle, route, and cell-context controls.

• Cy5-UTP for Fluorescent RNA Labeling

  2026-08-27

  Cy5-UTP enables direct, sensitive visualization of RNA produced by T7 in vitro transcription, supporting FISH, multiplex assays, and delivery studies without post-synthesis staining. Its strongest value is as a workflow bridge: researchers can track labeled RNA while separately measuring biological activity, uptake, or expression.

• Nintedanib (BIBF 1120): Mechanism and Research Use

  2026-08-26

  Nintedanib (BIBF 1120) is an orally active triple angiokinase inhibitor that blocks VEGFR, FGFR, and PDGFR signaling. Its research value spans angiogenesis inhibition, non-small cell lung cancer research, and idiopathic pulmonary fibrosis treatment models, while ATRX-deficient glioma findings provide a biomarker-informed rationale for studying multi-target RTK inhibitors.

• PreScission Protease (PSP): Cleavage Workflow

  2026-08-26

  PreScission Protease (PSP) is an HRV 3C protease fusion enzyme for selective removal of affinity tags from recombinant proteins containing its defined recognition sequence. It is suited to low-temperature protein purification workflows, but should not be used when the cleavage site is absent, inaccessible, or when the process requires conditions outside the enzyme’s validated product guidance.

• Recombinant Annexin V for Apoptosis Detection

  2026-08-25

  Brumatti, Sheridan, and Martin describe a practical bacterial-expression and purification workflow for recombinant polyhistidine-tagged annexin V, followed by FITC labeling for apoptosis analysis. The method converts phosphatidylserine exposure into a reproducible flow-cytometry or fluorescence-microscopy readout while clarifying the assay’s dependence on membrane biology and calcium-dependent binding.

• CCCP and Mitochondrial Imaging in Translational AD

  2026-08-25

  A translational framework for using CCCP as a controlled mitochondrial stressor alongside urine-derived stem cell imaging and deep learning in Alzheimer’s disease research.

• Foretinib: From Kinase Biology to Translation

  2026-08-24

  Foretinib (GSK1363089) offers translational researchers a way to interrogate coordinated Met and VEGFR signaling while separating growth arrest, cell death, motility, invasion, and metastatic behavior. This thought-leadership guide connects product pharmacology with response metrics, assay design, model selection, and evidence-driven experimental strategy.

• ATRX Loss Sensitizes Glioma Cells to RTK Inhibitors

  2026-08-24

  The reference study identified a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells were more sensitive to multi-targeted receptor tyrosine kinase and PDGFR inhibitors than comparator cells. Its combination data further indicate that RTK inhibition with Temozolomide may produce pronounced toxicity in ATRX-deficient models, supporting ATRX status as an important variable in glioma drug studies and clinical-trial interpretation.

• Resazurin Cell Viability Assay Kit for Bone Research

  2026-08-23

  Use the Resazurin Cell Viability Assay Kit to distinguish treatment-related loss of cell health from genuine changes in osteoblast differentiation during PORCN-inhibitor studies. Its live-cell-compatible fluorescence or colorimetric readout supports sensitive, scalable screening before ALP, mineralization, gene-expression, and mechanobiology endpoints.

7866 records 1/525 page Next 12345 下5页 Last page